KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 173 filers reported holding KARUNA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $27,151,288 | -16.7% | 160,573 | +6.8% | 0.01% | -9.1% |
Q2 2023 | $32,592,121 | +121776.2% | 150,298 | +2.1% | 0.01% | +10.0% |
Q1 2023 | $26,742 | +23.9% | 147,227 | +34.0% | 0.01% | +25.0% |
Q4 2022 | $21,587 | -99.9% | 109,857 | +13.3% | 0.01% | -11.1% |
Q3 2022 | $21,815,000 | +1537.8% | 96,986 | +28.8% | 0.01% | +800.0% |
Q2 2022 | $1,332,000 | +15.1% | 75,305 | +15.0% | 0.00% | – |
Q1 2022 | $1,157,000 | -0.9% | 65,457 | -0.8% | 0.00% | – |
Q4 2021 | $1,167,000 | -8.3% | 65,993 | -8.4% | 0.00% | – |
Q3 2021 | $1,273,000 | -15.5% | 72,023 | -15.4% | 0.00% | – |
Q2 2021 | $1,506,000 | +24.8% | 85,178 | +24.7% | 0.00% | – |
Q1 2021 | $1,207,000 | -0.7% | 68,297 | -0.7% | 0.00% | – |
Q4 2020 | $1,216,000 | -2.6% | 68,766 | -2.5% | 0.00% | – |
Q3 2020 | $1,248,000 | -2.6% | 70,540 | -2.6% | 0.00% | -100.0% |
Q2 2020 | $1,281,000 | -60.5% | 72,423 | +60.8% | 0.00% | -50.0% |
Q1 2020 | $3,242,000 | +91.3% | 45,031 | +100.2% | 0.00% | +100.0% |
Q4 2019 | $1,695,000 | – | 22,493 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |